From the newly generated lists of RBP-specific AS targets, we selected CD44 and NUMB for further analysis, based both on their ESRP1-specific AS patterns and on their well-established roles in EMT, stemness/differentiation, and cancer progression. The gene discussed is NUMB; the disease is cancer.